Abstract
The pharmaceutical industry has proven to be a somewhat fortunate anomaly over the past few years. To its left and its right - in the financial sector, the manufacturing sector and the technology sector - an increasingly demoralising war has been waged against costs. Looking to every corner of infrastructure and operations, the world seemed to hinge on streamlining processes and fighting to gain an edge that would enable another quarter of survival, however fiscally static.
| Original language | English |
|---|---|
| Pages (from-to) | 8-11 |
| Number of pages | 4 |
| Journal | European Pharmaceutical Contractor |
| Issue number | SPRING |
| Publication status | Published - Mar 2004 |
Fingerprint
ASJC Scopus subject areas
- Pharmaceutical Science
Cite this
The keys to R&D : The rise of enterprise asset management in the pharma industry. / Nanetti, Lorenzo; Desabris, Michael J.
In: European Pharmaceutical Contractor, No. SPRING, 03.2004, p. 8-11.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - The keys to R&D
T2 - The rise of enterprise asset management in the pharma industry
AU - Nanetti, Lorenzo
AU - Desabris, Michael J.
PY - 2004/3
Y1 - 2004/3
N2 - The pharmaceutical industry has proven to be a somewhat fortunate anomaly over the past few years. To its left and its right - in the financial sector, the manufacturing sector and the technology sector - an increasingly demoralising war has been waged against costs. Looking to every corner of infrastructure and operations, the world seemed to hinge on streamlining processes and fighting to gain an edge that would enable another quarter of survival, however fiscally static.
AB - The pharmaceutical industry has proven to be a somewhat fortunate anomaly over the past few years. To its left and its right - in the financial sector, the manufacturing sector and the technology sector - an increasingly demoralising war has been waged against costs. Looking to every corner of infrastructure and operations, the world seemed to hinge on streamlining processes and fighting to gain an edge that would enable another quarter of survival, however fiscally static.
UR - http://www.scopus.com/inward/record.url?scp=4444252005&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4444252005&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:4444252005
SP - 8
EP - 11
JO - EPC - European Pharmaceutical Contractor
JF - EPC - European Pharmaceutical Contractor
SN - 1364-369X
IS - SPRING
ER -